$SFIX

Bacos Anthony sold $282K of SFIX

Bacos Anthony (Chief Prod/Technology Officer) sold 70,000 shares of Stitch Fix, Inc. (SFIX) at an average of $4.04 ($4.03–$4.04, $0.28M total) across 2 trades on 2026-06-22 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Bacos Anthony
Published Jun 24, 2026, 1:34 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 24, 2026, 1:38 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$SFIX
Neutral
high confidence
Mentioned
$SFIX
Relevance
3/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$SFIXNeutralLow
01

Why it matters

This is a disclosed open-market sale by a Chief Product/Technology Officer, executed under a pre-arranged 10b5-1 plan; it does not introduce new company-specific fundamentals.

02

Market read

Primarily a sentiment/positioning datapoint; likely limited impact on valuation absent other catalysts.

03

What to watch

Traders may overreact to insider selling; without accompanying changes in guidance, buybacks, or performance metrics, the signal is typically weak.

Relevance 3/10Novelty 4/10Timing: SEC Form 4 filed 2026-06-24 for a 2026-06-22 sale

Background

The article is an SEC Form 4 insider transaction disclosure for Stitch Fix, Inc. (SFIX).

Company-level read

Ticker impact

$SFIXNeutralHigh confidence
Context

SEC Form 4 shows officer Bacos Anthony sold 70,000 Stitch Fix shares on 2026-06-22 under a 10b5-1 plan.

Expected impact

Low likelihood of a sustained price move solely from this disclosure.

Evidence & confidence

The filing is a pre-arranged 10b5-1 open-market sale by an officer; no new operating, guidance, or regulatory facts are disclosed.

Market effects

Minimal; insider-sale disclosures rarely change apparel/e-commerce sector fundamentals.

None indicated.

None indicated.

Counterpoint

Because the sale is under a 10b5-1 plan, it could be viewed as non-informational rather than bearish.

Key entities

  • Stitch Fix, Inc.

    Subject of the Form 4 insider transaction disclosure.

  • Bacos Anthony

    Chief Product/Technology Officer who sold shares.

  • 10b5-1 plan

    Pre-arranged plan that reduces interpretive value of the sale.

Related articles

$SFIXMedAI 8/10

Why Stitch Fix Stock Surged Today

Stitch Fix shares rose 15.69% on Thursday after the company reported fiscal 2026 Q3 results that beat investor expectations. Revenue increased 4.7% to $340 million; net revenue per active client rose 6.6% to $578. Net loss narrowed to $1.5 million, free cash flow was $6.5 million, and adjusted EBITDA rose 20% to $13.2 million. Stitch Fix raised full-year guidance to about $1.35 billion revenue and $49–$52 million adjusted EBITDA, with positive free cash flow.

$ORCLMedAI 8/10

Futures Rise, Oil Drops As US Ends Iran Strikes

US equity futures rose as tech and small caps gained after US Central Command said strikes against Iran were complete, easing concerns about further escalation and the Strait of Hormuz reopening. S&P futures rose 0.7% and Nasdaq 100 1.1%; bond yields fell 1–3bp. Brent slipped ~1% below $92; WTI fell to $88.87. Oracle shares fell ~8% after higher-than-estimated capex; Navan jumped 19% after raising revenue outlook.